Deep learning to diagnose pouch of Douglas obliteration with ultrasound sliding sign.

artificial intelligence computer-aided diagnosis deep learning endometriosis machine learning pelvic adhesions pouch of Douglas obliteration sliding sign ultrasonography

Journal

Reproduction & fertility
ISSN: 2633-8386
Titre abrégé: Reprod Fertil
Pays: England
ID NLM: 101778727

Informations de publication

Date de publication:
12 2021
Historique:
received: 08 05 2021
accepted: 25 08 2021
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 5 2 2022
Statut: epublish

Résumé

Pouch of Douglas (POD) obliteration is a severe consequence of inflammation in the pelvis, often seen in patients with endometriosis. The sliding sign is a dynamic transvaginal ultrasound (TVS) test that can diagnose POD obliteration. We aimed to develop a deep learning (DL) model to automatically classify the state of the POD using recorded videos depicting the sliding sign test. Two expert sonologists performed, interpreted, and recorded videos of consecutive patients from September 2018 to April 2020. The sliding sign was classified as positive (i.e. normal) or negative (i.e. abnormal; POD obliteration). A DL model based on a temporal residual network was prospectively trained with a dataset of TVS videos. The model was tested on an independent test set and its diagnostic accuracy including area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, and positive and negative predictive value (PPV/NPV) was compared to the reference standard sonologist classification (positive or negative sliding sign). In a dataset consisting of 749 videos, a positive sliding sign was depicted in 646 (86.2%) videos, whereas 103 (13.8%) videos depicted a negative sliding sign. The dataset was split into training (414 videos), validation (139), and testing (196) maintaining similar positive/negative proportions. When applied to the test dataset using a threshold of 0.9, the model achieved: AUC 96.5% (95% CI: 90.8-100.0%), an accuracy of 88.8% (95% CI: 83.5-92.8%), sensitivity of 88.6% (95% CI: 83.0-92.9%), specificity of 90.0% (95% CI: 68.3-98.8%), a PPV of 98.7% (95% CI: 95.4-99.7%), and an NPV of 47.7% (95% CI: 36.8-58.2%). We have developed an accurate DL model for the prediction of the TVS-based sliding sign classification. Endometriosis is a disease that affects females. It can cause very severe scarring inside the body, especially in the pelvis - called the pouch of Douglas (POD). An ultrasound test called the 'sliding sign' can diagnose POD scarring. In our study, we provided input to a computer on how to interpret the sliding sign and determine whether there was POD scarring or not. This is a type of artificial intelligence called deep learning (DL). For this purpose, two expert ultrasound specialists recorded 749 videos of the sliding sign. Most of them (646) were normal and 103 showed POD scarring. In order for the computer to interpret, both normal and abnormal videos were required. After providing the necessary inputs to the computer, the DL model was very accurate (almost nine out of every ten videos was correctly determined by the DL model). In conclusion, we have developed an artificial intelligence that can interpret ultrasound videos of the sliding sign that show POD scarring that is almost as accurate as the ultrasound specialists. We believe this could help increase the knowledge on POD scarring in people with endometriosis.

Identifiants

pubmed: 35118401
doi: 10.1530/RAF-21-0031
pii: RAF-21-0031
pmc: PMC8801033
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

236-243

Informations de copyright

© The authors.

Références

Ultrasound Obstet Gynecol. 2013 Jun;41(6):692-5
pubmed: 23400893
Ultrasound Obstet Gynecol. 2020 Sep;56(3):324-328
pubmed: 32112585
Ultrasound Obstet Gynecol. 2020 Dec;56(6):928-933
pubmed: 32198902
J Ultrasound Med. 2020 Dec;39(12):2295-2303
pubmed: 32412170
J Minim Invasive Gynecol. 2019 Mar - Apr;26(3):477-483
pubmed: 29890354
Ultrasound Obstet Gynecol. 2013 Jun;41(6):685-91
pubmed: 23001892
Hum Reprod. 2012 Dec;27(12):3412-6
pubmed: 22990516
Hum Reprod. 2014 Jun;29(6):1199-204
pubmed: 24777849
Hum Reprod. 2011 Jul;26(7):1741-51
pubmed: 21540244
J Ultrasound Med. 2019 Dec;38(12):3155-3161
pubmed: 31037752
BJOG. 2019 Nov;126(12):1499-1506
pubmed: 31452295
Ultrasound Obstet Gynecol. 2016 Sep;48(3):318-32
pubmed: 27349699
Stat Med. 2007 May 10;26(10):2170-83
pubmed: 16927452
Am J Obstet Gynecol. 2019 Aug;221(2):86-94
pubmed: 30790565
Ultrasound Obstet Gynecol. 2016 Jul;48(1):113-20
pubmed: 26214843
J Minim Invasive Gynecol. 2020 May - Jun;27(4):892-900
pubmed: 31279776
Obstet Gynecol. 2018 Mar;131(3):529-533
pubmed: 29420398
Int J Womens Health. 2018 Sep 17;10:529-536
pubmed: 30271220
Radiographics. 2019 Sep-Oct;39(5):1549-1568
pubmed: 31498746
Cochrane Database Syst Rev. 2016 Feb 26;2:CD009591
pubmed: 26919512
J Minim Invasive Gynecol. 2021 Jan;28(1):57-62
pubmed: 32289555
Clin Chem. 2015 Dec;61(12):1446-52
pubmed: 26510957
Ultraschall Med. 2006 Feb;27(1):79-105
pubmed: 16508866

Auteurs

Gabriel Maicas (G)

Australian Institute for Machine Learning, University of Adelaide, Adelaide, Australia.

Mathew Leonardi (M)

OMNI Gynaecological Ultrasound and Care, Sydney, Australia.
Sydney Medical School Nepean, University of Sydney, Sydney, Australia.
Department of Obstetrics and Gynecology, McMaster University, Hamilton, Canada.

Jodie Avery (J)

Robinson Research Institute, University of Adelaide, Adelaide, Australia.

Catrina Panuccio (C)

Specialist Imaging Partners, North Adelaide, Australia.

Gustavo Carneiro (G)

Australian Institute for Machine Learning, University of Adelaide, Adelaide, Australia.

M Louise Hull (ML)

Robinson Research Institute, University of Adelaide, Adelaide, Australia.
Discipline of Obstetrics and Gynaecology, Women & Children's Hospital, Adelaide, Australia.

George Condous (G)

OMNI Gynaecological Ultrasound and Care, Sydney, Australia.
Sydney Medical School Nepean, University of Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH